Page last updated: 2024-11-12
calothrixin a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
calothrixin A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 9926867 |
CHEMBL ID | 435295 |
SCHEMBL ID | 2231059 |
MeSH ID | M0376608 |
Synonyms (5)
Synonym |
---|
CHEMBL435295 |
calothrixin a |
SCHEMBL2231059 |
20-oxido-10-aza-20-azoniapentacyclo[11.8.0.03,11.04,9.014,19]henicosa-1(13),3(11),4,6,8,14,16,18,20-nonaene-2,12-dione |
DTXSID601046871 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (84)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID422423 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G0 phase at 1 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID422429 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at S phase at 0.1 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701939 | Antiproliferative activity against human SiHa cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1911370 | Cytotoxicity against human MDA-MB-231 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay | |||
AID1701941 | Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422424 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G0 phase at 0.1 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1911379 | Inhibition of DNA topoisomerase I (unknown origin) relaxation activity at 100 uM incubated for 30 mins by chemiDoc system | |||
AID1911371 | Cytotoxicity against human HCT-116 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay | |||
AID1701944 | Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701937 | Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422409 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G2/M phase at 0.1 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701949 | Anticlonogenic activity against human NCI-H460 cells assessed as inhibition of colony formation incubated for 48 hrs followed by compound washout with PBS and measured after 14 days by crystal violet staining based analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422428 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at subG1 phase at 10 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701964 | Induction of cell cycle arrest in human HCT-116 cells assessed as accumulation of cells at sub-G1 phase at 2 uM incubated for 48 hrs by propidium iodide staining based flow cytometry analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701965 | Induction of cell cycle arrest in human HCT-116 cells assessed as accumulation of cells at sub-G1 phase at 5 uM incubated for 48 hrs by propidium iodide staining based flow cytometry analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422416 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at S phase at 10 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1702014 | Octanol/buffer distribution coefficient, log D of the compound at pH 7.4 | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701940 | Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1911369 | Cytotoxicity against human SH-SY5Y cells expressing low level of topoisomerase I/II measured after 72 hrs by MTT assay | |||
AID1911403 | Induction of cell cycle arrest in human A-375 cells assessed as accumulation of cells at S phase at 80 nM incubated for 24 hrs by PI based flow cytometric analysis (RVB = 26.73%) | |||
AID1701942 | Antiproliferative activity against human HCT-116 p53-/- cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422430 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at S phase at 1 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1702013 | Octanol/water partition coefficient, log P of the compound | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701988 | Induction of apoptosis in human HeLa cells assessed as increase in cleaved PARP levels at 1 uM by Western blot analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422408 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G2/M phase at 1 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID422418 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G2/M phase at 1 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701971 | Inhibition of recombinant human topoisomerase 2 assessed as decrease in relaxation of supercoiled pBlue-Script KS(+) plasmid DNA at < 100 uM incubated for 30 mins by ethidium bromide staining based gel electrophoresis method | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701943 | Antiproliferative activity against human U-251 cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422425 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G0 phase at 1 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701977 | Induction of DNA damage in human HCT-116 cells assessed as tail length at 0.5 uM incubated for 48 hrs by alkaline Comet assay relative to control | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701969 | Inhibition of wild-type recombinant human topoisomerase 1 expressed in baculovirus infected Sf9 cells assessed as decrease in relaxation of supercoiled pBlue-Script KS(+) plasmid DNA at 200 uM incubated for 30 mins by ethidium bromide staining based gel e | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422406 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G0 phase at 10 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID422419 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G2/M phase at 10 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701994 | Induction of apoptosis in human HCT-116 cells assessed as reduction in PARP protein levels at 3 uM incubated for 48 hrs by Western blot analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1911375 | Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay | |||
AID1911384 | Antiproliferative activity against doxorubicin resistant human HCT-116 cells measured after 72 hrs by MTT assay | |||
AID1911402 | Induction of cell cycle arrest in human A-375 cells assessed as accumulation of cells at G1 phase at 80 nM incubated for 24 hrs by PI based flow cytometric analysis (RVB = 52.94%) | |||
AID1702002 | Binding affinity to calf thymus DNA assessed as hypsochromic shift absorbance measured at 284 nM at 3*10^-5 mol/L by double beam UV-Vis spectroscopic analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1911372 | Cytotoxicity against human MCF7 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay | |||
AID1911401 | Antiinvasive activity in human A-375 cells assessed as reduction in cell migration at 40 nM incubated for 24 hrs by crystal violet staining method | |||
AID1701954 | Induction of cell cycle arrest in human HCT-116 cells assessed as accumulation of cells at S phase at 5 uM incubated for 20 hrs by propidium iodide staining based flow cytometry analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1702004 | Binding affinity to calf thymus DNA assessed as hyperchromic shift measured at 432 nm at 3*10^-5 mol/L by double beam UV-Vis spectroscopic analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422417 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G2/M phase at 0.1 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID422431 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at S phase at 10 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID422407 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at subG1 phase at 0.1 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701962 | Induction of cell cycle arrest in human HCT-116 cells assessed as accumulation of cells at G1/S phase at 2 uM incubated for 48 hrs by propidium iodide staining based flow cytometry analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701957 | Induction of cell cycle arrest in human HCT-116 cells assessed as accumulation of cells at S phase at 5 uM incubated for 3 to 20 hrs in presence of 0.3 uM mitotic inhibitor nocodazole by propidium iodide staining based flow cytometry analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1702003 | Binding affinity to calf thymus DNA assessed as hyperchromic shift measured at 362 nm at 3*10^-5 mol/L by double beam UV-Vis spectroscopic analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701982 | Induction of apoptosis in human HCT-116 cells assessed as chromatin condensation at 2 uM incubated for 48 hrs by acridine orange/propidium iodide double staining based fluorescence microscopy analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1911399 | Inhibition of colony formation in human HCT-116 cells at 40 nM incubated for 48 hrs by crystal violet staining method | |||
AID422411 | Induction of human DNA topoisomerase 1-mediated DNA cleavage at 1 to 10 uM by polyacrylamide gel electrophoresis | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701945 | Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701983 | Induction of apoptosis in human HCT-116 cells assessed as nuclear fragmentation at 2 uM incubated for 48 hrs by acridine orange/propidium iodide double staining based fluorescence microscopy analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1911404 | Induction of cell cycle arrest in human A-375 cells assessed as accumulation of cells at G2 phase at 80 nM incubated for 24 hrs by PI based flow cytometric analysis (RVB = 20.34%) | |||
AID422405 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G0 phase at 0.1 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID670966 | Antimalarial activity against chloroquine sensitive Plasmodium falciparum FCR-3 | 2012 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14 | Synthesis and antimalarial activity of calothrixins A and B, and their N-alkyl derivatives. |
AID1911373 | Cytotoxicity against human A-375 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay | |||
AID1701985 | Induction of apoptosis in human NCI-H460 cells assessed as nuclear fragmentation at 2 uM incubated for 48 hrs by acridine orange/propidium iodide double staining based fluorescence microscopy analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422415 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at S phase at 1 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701948 | Anticlonogenic activity against human HCT-116 cells assessed as inhibition of colony formation incubated for 48 hrs followed by compound washout with PBS and measured after 14 days by crystal violet staining based analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID246030 | Cytotoxicity against HeLa cell lines | 2004 | Journal of medicinal chemistry, Sep-23, Volume: 47, Issue:20 | Synthesis, electrochemistry, and bioactivity of the cyanobacterial calothrixins and related quinones. |
AID1702011 | Binding affinity to calf thymus DNA assessed as binding constant at 298 K by double beam UV-vis spectroscopic analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701970 | Inhibition of recombinant human topoisomerase 2 assessed as decrease in relaxation of supercoiled pBlue-Script KS(+) plasmid DNA at 200 uM incubated for 30 mins by ethidium bromide staining based gel electrophoresis method | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1701992 | Induction of apoptosis in human NCI-H460 cells assessed as increase in cleaved PARP protein levels at 3 uM incubated for 48 hrs by Western blot analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422422 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at subG1 phase at 10 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701960 | Induction of cell cycle arrest in human HeLa cells assessed as accumulation of cells at S phase at 1 uM incubated for 3 to 20 hrs in presence of 0.3 uM mitotic inhibitor nocodazole by propidium iodide staining based flow cytometry analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422421 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at subG1 phase at 1 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1911378 | Aqueous solubility of the compound in saline equilibrating for 24 hrs by HPLC analysis | |||
AID1702000 | Binding affinity to calf thymus DNA assessed as hypochromic effect at 3*10^-5 mol/L by double beam UV-Vis spectroscopic analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1911376 | Cytotoxicity against human HEK293T cells measured after 72 hrs by MTT assay | |||
AID422413 | Reversal of drug-stabilized human DNA topoisomerase 1-DNA binary complex at 5 uM within 5 mins by polyacrylamide gel electrophoresis in presence of 0.35 M NaCl | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701984 | Induction of apoptosis in human NCI-H460 cells assessed as chromatin condensation at 2 uM incubated for 48 hrs by acridine orange/propidium iodide double staining based fluorescence microscopy analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422426 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G0 phase at 10 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID422420 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at subG1 phase at 0.1 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1911374 | Cytotoxicity against human A549 cells expressing high level of topoisomerase I/II measured after 72 hrs by MTT assay | |||
AID1701953 | Induction of cell cycle arrest in human HCT-116 cells assessed as accumulation of cells at G0/G1 phase at 5 uM incubated for 20 hrs by propidium iodide staining based flow cytometry analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID1911385 | Antiproliferative activity against doxorubicin sensitive human HCT-116 cells measured after 72 hrs by MTT assay | |||
AID1911398 | Inhibition of colony formation in human A-375 cells at 40 nM incubated for 48 hrs by crystal violet staining method | |||
AID422414 | Cytotoxicity against p38-proficient human CCRF-CEM cells after 3 days by MTT assay | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701938 | Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by sulphorhodamine B assay | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422432 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at G2/M phase at 10 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID422427 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at subG1 phase at 1 uM treated for 3 hrs followed by drug washout and 15 hrs incubation in drug free medium by flow cytometry | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
AID1701961 | Induction of cell cycle arrest in human HeLa cells assessed as accumulation of cells at G1 phase at 1 uM incubated for 3 to 20 hrs in presence of 0.3 uM mitotic inhibitor nocodazole by propidium iodide staining based flow cytometry analysis | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues. |
AID422410 | Cell cycle arrest in human CCRF-CEM cells assessed as accumulation at S phase at 0.1 uM treated for 3 hrs measured for 15 hrs after nocodazole treatment by flow cytometry in presence of mitotic inhibitor nocodazole | 2009 | Journal of natural products, Mar-27, Volume: 72, Issue:3 | Calothrixins, a new class of human DNA topoisomerase I poisons. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (14)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.36) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (7.14%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (92.86%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |